Skip to Main Content

Paper Details

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.
Oncotarget
61
2017
CAG, CAG, Nse, NEFL, Dermo1, P0, Sox9 and Osterix promoters, Col1a2.3, Col1a3, Cre, Dermo1, ES, ES cells, EWS, Ewing sarcoma, FLI1, NEFL, Nse, Osterix promoters, P0, Prx1, Runx2, Runx2, Col1a2, Sox9, developmental defects, embryonic lethality, mouse, murine, specific sites, tumor
Author NameAffiliation
Didier SurdezInstitut Curie Research Center, PSL Research University
Didier SurdezINSERM U, Institut Curie Research Center
Franck TirodeInstitut Curie Research Center, PSL Research University
Franck TirodeINSERM U, Institut Curie Research Center
Jeffrey A ToretskyGeorgetown University Medical Center
Jeffrey A ToretskyGeorgetown University Medical Center
Heinrich KovarMedical University of Vienna
Heinrich KovarChildren's Cancer Research Institute
Heinrich KovarMedical University of Vienna
Heinrich KovarChildren's Cancer Research Institute
E Alejandro Sweet-CorderoStanford University School of Medicine
E Alejandro Sweet-CorderoStanford University School of Medicine
Takuro NakamuraThe Cancer Institute, Japanese Foundation for Cancer Research
Richard MorigglLudwig Boltzmann Institute for Cancer Research
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine
Richard MorigglMedical University of Vienna
Olivier DelattreInstitut Curie Research Center, PSL Research University
Olivier DelattreINSERM U, Institut Curie Research Center
Olivier DelattreInstitut Curie
Aykut UrenGeorgetown University Medical Center
Aykut UrenGeorgetown University Medical Center
  • 1 - 21

Datasets

Release 1.2